Description
O04 OPTIMAL ANTITHROMBOTIC REGIMEN IN PATIENTS WITH CARDIOGENIC SHOCK ON IMPELLATM MECHANICAL SUPPORT: LESS MIGHT BE MORE
Article: O04 OPTIMAL ANTITHROMBOTIC REGIMEN IN PATIENTS WITH CARDIOGENIC SHOCK ON IMPELLATM MECHANICAL SUPPORT: LESS MIGHT BE MORE
€3.03
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: INTRODUCTION
€3.03 Add to cart
Reviews
There are no reviews yet.